Aug 27 (Reuters) - Jazz Pharmaceuticals Inc:
* Says it and unit entered into a settlement and sub-license agreement with
Anchen inc and its unit
* In the suit, co, Elan Pharma International Limited sued Anchen for
infringement of Elan's patent of Luvox
* It and Anchen have agreed to dismiss all claims brought in the litigation
without prejudice-SEC filing
* Anchen has agreed not to contest the validity or enforceability of the patent
in the United States
* Pharma-has granted sub-license to anchen of rights to manufacture, market and
sell generic version of Luvox cr in U.S.
* Says co is exclusive licensee of patent under deal between co and Elan - SEC
filing
((Bangalore Equities Newsroom; +91 80 4135 5800; within U.S. +1 646 223 8780))
(For more news, please click here) COPYRIGHT Copyright Thomson Reuters 2010. All rights reserved. The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.
* Says it and unit entered into a settlement and sub-license agreement with
Anchen inc and its unit
* In the suit, co, Elan Pharma International Limited sued Anchen for
infringement of Elan's patent of Luvox
* It and Anchen have agreed to dismiss all claims brought in the litigation
without prejudice-SEC filing
* Anchen has agreed not to contest the validity or enforceability of the patent
in the United States
* Pharma-has granted sub-license to anchen of rights to manufacture, market and
sell generic version of Luvox cr in U.S.
* Says co is exclusive licensee of patent under deal between co and Elan - SEC
filing
((Bangalore Equities Newsroom; +91 80 4135 5800; within U.S. +1 646 223 8780))
(For more news, please click here) COPYRIGHT Copyright Thomson Reuters 2010. All rights reserved. The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.